PMID- 20428186 OWN - NLM STAT- MEDLINE DCOM- 20100805 LR - 20211020 IS - 1523-1747 (Electronic) IS - 0022-202X (Print) IS - 0022-202X (Linking) VI - 130 IP - 8 DP - 2010 Aug TI - Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth. PG - 2031-40 LID - 10.1038/jid.2010.98 [doi] AB - The EGFR ligand amphiregulin (AREG) has been implicated as an important autocrine growth factor in several epithelial malignancies and in psoriasis, a hyperproliferative skin disorder. To characterize the mechanisms by which AREG regulates autocrine epithelial cell growth, we transduced human keratinocytes (KCs) with lentiviral constructs expressing tetracycline (TET)-inducible small hairpin RNA (shRNA). TET-induced expression of AREG shRNA markedly reduced autocrine extracellular signal-regulated kinase phosphorylation, strongly inhibited autocrine KC growth with an efficiency similar to metalloproteinase and EGFR inhibitors, and induced several markers of KC differentiation, including keratins 1 and 10. Addition of various concentrations of exogenous EGFR ligands to KC cultures reversed the growth inhibition in response to AREG-blocking antibodies but not to shRNA-mediated AREG knockdown. Lentivirus-mediated expression of the full-length AREG transmembrane (TM) precursor, but not of the AREG extracellular domain, markedly reversed the shRNA-mediated growth inhibition and morphological changes, and strongly reduced the induction of multiple markers of KC differentiation. Taken together, our data show that autocrine human KC growth is highly dependent on the AREG TM precursor protein and strongly suggest a previously unreported function of the metalloproteinase-processed carboxy (C)-terminal domain of AREG. FAU - Stoll, Stefan W AU - Stoll SW AD - Department of Dermatology, University of Michigan, Ann Arbor, Michigan 48109, USA. sstoll@umich.edu FAU - Johnson, Jessica L AU - Johnson JL FAU - Li, Yong AU - Li Y FAU - Rittie, Laure AU - Rittie L FAU - Elder, James T AU - Elder JT LA - eng GR - R03 AR049420/AR/NIAMS NIH HHS/United States GR - R01 AR052889-04/AR/NIAMS NIH HHS/United States GR - K01 AR050462-04/AR/NIAMS NIH HHS/United States GR - R03 AR049420-03/AR/NIAMS NIH HHS/United States GR - K01 AR050462/AR/NIAMS NIH HHS/United States GR - R01 AR052889/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20100429 PL - United States TA - J Invest Dermatol JT - The Journal of investigative dermatology JID - 0426720 RN - 0 (AREG protein, human) RN - 0 (Amphiregulin) RN - 0 (EGF Family of Proteins) RN - 0 (Glycoproteins) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Ligands) RN - 0 (Protein Precursors) RN - 0 (RNA, Small Interfering) RN - EC 2.7.10.1 (ErbB Receptors) SB - IM CIN - J Invest Dermatol. 2010 Aug;130(8):1966-8. PMID: 20631750 MH - Amphiregulin MH - Autocrine Communication/*physiology MH - Cell Differentiation/physiology MH - Cell Division/physiology MH - Cell Line MH - EGF Family of Proteins MH - ErbB Receptors/metabolism MH - Glycoproteins/*chemistry/genetics/*metabolism MH - Humans MH - Intercellular Signaling Peptides and Proteins/*chemistry/genetics/*metabolism MH - Keratinocytes/*cytology/*metabolism MH - Lentivirus/genetics MH - Ligands MH - Phosphorylation/physiology MH - Protein Precursors/metabolism MH - Protein Structure, Tertiary MH - RNA, Small Interfering MH - Signal Transduction/physiology MH - Transduction, Genetic PMC - PMC3072808 MID - NIHMS190448 EDAT- 2010/04/30 06:00 MHDA- 2010/08/06 06:00 PMCR- 2011/04/08 CRDT- 2010/04/30 06:00 PHST- 2010/04/30 06:00 [entrez] PHST- 2010/04/30 06:00 [pubmed] PHST- 2010/08/06 06:00 [medline] PHST- 2011/04/08 00:00 [pmc-release] AID - S0022-202X(15)34943-5 [pii] AID - 10.1038/jid.2010.98 [doi] PST - ppublish SO - J Invest Dermatol. 2010 Aug;130(8):2031-40. doi: 10.1038/jid.2010.98. Epub 2010 Apr 29.